FDA Inspection
Sanofi Winthrop IndustrieSanofi Winthrop Industrie – FDA Inspection, Feb 14, 2017
Record Details
This FDA Inspection record concerns Sanofi Winthrop Industrie, with an inspection on February 14, 2017, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 85eb3375-0a78-4ecc-8a67-ce47a8683bf4
Inspection Facts
- Inspection number
- 1001237
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Sanofi Winthrop Industrie
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2026 | Not classified | Office of Inspections and Investigations | Vaccines and Allergenic Products |
| April 25, 2023 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 7, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2019 | Not classified | Office of Inspections and Investigations | |
| May 25, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Sanofi Winthrop Industrie
- FDA Inspection 1337194 - 2026-09-24
- FDA Inspection 1206033 - 2023-04-25
- FDA Inspection 1133485 - 2020-02-07
- FDA Inspection 1086137 - 2019-03-01
- FDA Inspection 1058039 - 2018-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.